Working to Eradicate Gynecologic Cancers

David Griffin, MD

Attending Physician
Anmed Gynecologic Oncology/Upstate Oncology Associates
116 Shire Dr
Anderson, SC
USA 29621

Papers:
53 A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study